Benzinga's Top #PreMarket Gainers

Esperion Therapeutics ESPR shares jumped 29.89% to $31.72 in pre-market trading after the company announced positive top-line Phase 2b results for ETC-1002. RealD RLD shares jumped 20.60% to $11.30 in pre-market trading after Starboard Value offered to acquire the rest of the shares in RealD RLD for $12 per share. Starboard Value disclosed in a SEC filing that it had taken a 10% stake in RealD. Ariad Pharmaceuticals ARIA shares surged 12.50% to $5.94 in pre-market trading after the company reported that its investigational cancer medicine, AP26113, has received Breakthrough Therapy designation by the FDA for ALK+ non-small cell lung cancer resistant to crizotinib. Tesla Motors TSLA gained 5.26% to $252.87 in pre-market trading. Tesla CEO Elon Musk tweeted a teaser about a mysterious unveiling of what he called the "D" on October 9.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!